Jasper M J, Brännström M, Olofsson J I, Petrucco O M, Mason H, Robertson S A, Norman R J
Department of Obstetrics and Gynaecology, University of Adelaide, Queen Elizabeth Hospital, Woodville, Australia.
Mol Hum Reprod. 1996 Aug;2(8):555-62. doi: 10.1093/molehr/2.8.555.
In recent years it has become evident that a leukocyte-cytokine network contributes to the paracrine regulation of ovarian function. The objectives of this study were to examine the presence of a potent lympho-haemopoietic cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), in tissues and fluids from human ovaries. In a prospective study, follicular fluid and plasma were collected from naturally cycling women and women undergoing hyperstimulation for in-vitro fertilization (IVF). Granulosa-lutein cells were collected at the time of oocyte recovery for IVF and corpora lutea were collected at the time of hysterectomy for non-ovarian reasons. Culture supernatants from ovarian cell and tissue cultures were harvested on completion of a 48 h incubation. Immunoactive GM-CSF was measured by enzyme-linked immunosorbent assay, and was found to be present at statistically significantly higher levels in follicular fluid (8.9 +/- 0.7 pg/ml) and plasma (11.3 +/- 0.8 pg/ml) of women undergoing hyperstimulation compared to follicular fluid (5.3 +/- 0.3 pg/ml) and plasma (7.1 +/- 0.5 pg/ml) from naturally cycling women. Immunoactive GM-CSF was also detected in culture supernatants of granulosa-lutein cells (47.6 pg/10(5) cells), early luteal phase corpora lutea (0.52 pg/microgram DNA) and mid-luteal phase corpora lutea (0.98 pg/microgram DNA). Furthermore, transcripts for GM-CSF, and both the alpha and beta subunits of the GM-CSF receptor, were detected by reverse transcription polymerase chain reaction (RT-PCR) in granulosa-lutein cell culture preparations and corpora lutea collected during the early, mid- and late luteal phase of the menstrual cycle. These results show that GM-CSF is expressed and secreted by cells within the human ovary, and, together with the finding of expression of mRNA for GM-CSF receptor, suggest a role for GM-CSF in the local regulation of ovarian events.
近年来,白细胞 - 细胞因子网络参与卵巢功能旁分泌调节这一点已变得很明显。本研究的目的是检测一种强大的淋巴细胞造血细胞因子,即粒细胞 - 巨噬细胞集落刺激因子(GM - CSF)在人卵巢组织和体液中的存在情况。在一项前瞻性研究中,从自然周期的女性以及接受体外受精(IVF)超刺激的女性中收集卵泡液和血浆。在IVF取卵时收集颗粒黄体细胞,在因非卵巢原因进行子宫切除时收集黄体。卵巢细胞和组织培养48小时结束后收集培养上清液。通过酶联免疫吸附测定法测量免疫活性GM - CSF,发现与自然周期女性的卵泡液(5.3±0.3 pg/ml)和血浆(7.1±0.5 pg/ml)相比,接受超刺激的女性的卵泡液(8.9±0.7 pg/ml)和血浆(11.3±0.8 pg/ml)中GM - CSF的水平在统计学上显著更高。在颗粒黄体细胞培养上清液(47.6 pg/10⁵细胞)、黄体早期(0.52 pg/μg DNA)和黄体中期(0.98 pg/μg DNA)的黄体中也检测到免疫活性GM - CSF。此外,通过逆转录聚合酶链反应(RT - PCR)在月经周期黄体早期、中期和晚期收集的颗粒黄体细胞培养物和黄体中检测到GM - CSF及其受体的α和β亚基的转录本。这些结果表明,GM - CSF由人卵巢内的细胞表达和分泌,并且,连同GM - CSF受体mRNA表达的发现,提示GM - CSF在卵巢局部事件调节中发挥作用。